Patients in areas across the country now have access to Deep Transcranial Magnetic Stimulation (Deep TMS) therapy as an aid for short-term smoking cessation
BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive treatment of brain disorders, today announced the distribution of its first 10 Deep Transcranial Magnetic Stimulation (Deep TMS) devices for smoking addiction to practices across the United States. The recently FDA-cleared aid for short-term smoking cessation offers a noninvasive treatment that administers electromagnetic pulses using BrainsWay’s patented H4-coil through a cushioned helmet, stimulating neurons in brain structures associated with addiction.
Deep TMS is the first FDA-cleared noninvasive treatment in the addiction space for any TMS device, and currently serves as the only TMS platform technology with clinical outcome data for multiple brain disorders. In 2019, a double-blind, sham-controlled, multicenter randomized controlled trial of 262 patients found Deep TMS to be an effective treatment, significantly improving the continuous quit rate, as well as reducing craving and the average number of cigarettes smoked per week. Participants in the study were highly addicted to smoking with a history of smoking an average of over 26 years and multiple failed attempts to quit.
Deep TMS treatment for smoking addiction is currently available at the following clinics:
Advanced Mental Health Care in Palm Beach, FL
Brooklyn Minds in New York, NY
Delray Center for Healing in Delray Beach, FL
Greenbrook TMS NeuroHealth in Richmond Heights, MO
Houston TMS Therapeutics in Bellaire, TX
Kadima Neuropsychiatry Institute in La Jolla, CA
Medical University of South Carolina (MUSC) in Charleston, SC
Novus TMS in Tuscaloosa, AL
PsyCare Inc. in Charleston, WV
TMS NW in Vancouver, WA
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.